Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 9 January 2026

Apple stock snaps 7-session skid as Evercore lifts target; Apple Card switch looms

Apple stock snaps 7-session skid as Evercore lifts target; Apple Card switch looms

Apple shares rose 0.13% to $259.37 Friday, ending a seven-day losing streak. Evercore raised its price target to $330 and lifted quarterly estimates ahead of Apple’s Jan. 29 results. Apple and Chase set a roughly 24-month timeline to move the Apple Card portfolio from Goldman Sachs. CEO Tim Cook received $74.3 million in 2025 compensation, mostly in stock awards.
9 January 2026
··
Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar shares fell 5.9% to $20.90 in Friday’s Nasdaq session after the company reported preliminary 2025 retail sales of about 60,119 cars, up 34%, and a 27% rise in fourth-quarter volumes. The company said a December ADS ratio change restored compliance with Nasdaq’s $1 bid-price rule. CEO Michael Lohscheller set Feb. 18 for a strategy update. Europe now accounts for 78% of sales as U.S. tariffs and competition weigh.
9 January 2026
··
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers shares dropped 5.3% to $32.06 after Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill. Bank of America cut its price target on Hims, citing margin and spending risks for 2026. The stock fell from an intraday high of $34.35. Investors are watching for signs of pricing pressure and updated forecasts ahead of Hims’ next earnings report.
9 January 2026
··
Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands shares fell 4.3% to $59.25 Friday afternoon, underperforming a rising U.S. market. Analysts cited concerns over Macau operating costs and fourth-quarter margins after Sands China and Melco Resorts dropped sharply in Hong Kong. Other casino stocks with Macau exposure also declined. Investors are watching for the company’s next results update later this month.
9 January 2026
·
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.
9 January 2026
···
Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines (LUNR) stock slides after Stifel downgrade as NASA moon rover decision nears

Intuitive Machines shares fell 3.8% to $18.88 Friday after Stifel downgraded the stock to “hold,” citing uncertainty over a pending NASA rover contract. The stock swung between $17.82 and $19.73 on heavy volume. NASA’s Lunar Terrain Vehicle award remains undecided. Investors are also watching for U.S. inflation data on Jan. 13 and company earnings on March 19.
9 January 2026
··
Valero Energy stock dips on Piper Sandler target cut as Venezuela talks keep traders guessing

Valero Energy stock dips on Piper Sandler target cut as Venezuela talks keep traders guessing

Valero Energy shares fell 3% to $185.50 in mid-afternoon New York trading, while the S&P 500 ETF rose 0.8%. The White House is meeting with oil firms including Valero and Marathon to discuss possible investment in Venezuela’s energy sector. Valero plans to keep importing gasoline into Northern California after its Benicia refinery idles in April. Fourth-quarter results are due Jan. 29.
9 January 2026
·····
Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Why Equity Residential stock is sliding today: BMO downgrade meets a $400 million asset sale

Equity Residential shares fell 3.8% to $60.46 after BMO Capital downgraded the stock, citing softening rental markets in major coastal cities. The drop followed news of a $400 million sale of three properties to JRK Property Holdings. Other large apartment REITs also traded lower. Investors are watching for upcoming U.S. inflation data and Equity Residential’s earnings on Feb. 2.
9 January 2026
···
Freeport-McMoRan (FCX) stock jumps as copper firms and JPMorgan lifts target ahead of earnings

Freeport-McMoRan (FCX) stock jumps as copper firms and JPMorgan lifts target ahead of earnings

Freeport-McMoRan shares rose 4.4% to $56.59 Friday as copper prices climbed and JPMorgan raised its price target to $68. Goldman Sachs also lifted its copper forecast for the first half of 2026. Investors face a Jan 15 dividend record date and await the Jan 22 earnings report. Rio Tinto confirmed early merger talks with Glencore, sending sector shares moving.
9 January 2026
··
1 … 412 413 414 415 416 … 1,174

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop